SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
+35.99%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.46B
AUM Growth
+$403M
(+38%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
8.68%
Top 10 Holdings %
Top 10 Hldgs %
62.29%
Holding
88
New
21
Increased
19
Reduced
9
Closed
13
Top Buys
| 1 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$34.1M |
| 2 |
Gilead Sciences
GILD
|
$31M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$26.9M |
| 4 |
Eli Lilly
LLY
|
$24.4M |
| 5 |
AbbVie
ABBV
|
$19.8M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$27.6M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$21.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$20.4M |
| 4 |
Biogen
BIIB
|
$16.7M |
| 5 |
Merus
MRUS
|
$10.5M |
Sector Composition
| 1 | Healthcare | 98.35% |
